Japan Tissue Engineering Co., Ltd. (TYO:7774)
Japan · Delayed Price · Currency is JPY 618.00
+25.00 (4.22%)
May 12, 2026, 3:30 PM JST
Japan Tissue Engineering Market Cap
Japan Tissue Engineering has a market cap or net worth of 25.1 billion as of May 12, 2026. Its market cap has increased by 51.10% in one year.
Market Cap
25.10B
Enterprise Value
21.85B
Revenue
2.18B
Ranking
n/a
PE Ratio
n/a
Stock Price
618.00
Market Cap Chart
Since December 21, 2007, Japan Tissue Engineering's market cap has increased from 5.99B to 25.10B, an increase of 318.82%. That is a compound annual growth rate of 8.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 24.08B | -4.66% |
| Dec 30, 2025 | 25.26B | 34.34% |
| Dec 30, 2024 | 18.80B | -8.50% |
| Dec 29, 2023 | 20.55B | 8.35% |
| Dec 30, 2022 | 18.96B | -17.49% |
| Dec 30, 2021 | 22.99B | -8.12% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Healios K.K. | 46.44B |
| AnGes | 21.01B |
| RaQualia Pharma | 20.69B |
| StemRIM | 18.80B |
| Stella Pharma | 18.57B |
| Renascience | 17.33B |
| ReproCELL | 16.54B |
| CanBas | 13.05B |